Yang C - Search Results

1

A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells.

Liu R, Zhang Y, Chen Y, Qi J, Ren S, Xushi MY, Yang C, Zhu H, Xiong D. Liu R, et al. Among authors: yang c. J Pharm Sci. 2010 Jul;99(7):3266-75. doi: 10.1002/jps.22082. J Pharm Sci. 2010. PMID: 20112430

2

[Effect of calmodulin antagonist EBB on invasion of human fibrosarcoma cell HT1080].

Pan B, Zhou Y, Qi J, Xiong DS, Liu JW, Qi SL, Cheng YH, Yang CZ, Zhu HF. Pan B, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Jun;27(3):311-4. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005. PMID: 16038266 Chinese.

3

[Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].

Cheng YH, Qi J, Xiong DS, Liu JW, Qi SL, Pan B, Yang CZ, Zhu HF. Cheng YH, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Apr;28(2):164-8. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16733896 Chinese.

4

[Effect of calmodulin antagonist O-4-ethoxyl- butyl-berbamine on the proliferation of human breast cancer cell line MCF-7 and its relevant mechanism].

Dai XH, Liu R, Zhou Y, Yang M, Fan DM, Xiong DS, Qi J, Yang CZ, Zhu HF. Dai XH, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Jun;31(3):326-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009. PMID: 19621518 Chinese.

5

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.

Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D. Liu F, et al. Among authors: yang c. Life Sci. 2008 Sep 26;83(13-14):496-501. doi: 10.1016/j.lfs.2008.07.017. Epub 2008 Aug 3. Life Sci. 2008. PMID: 18725232

6

Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance.

Qi J, Yang CZ, Wang CY, Wang SB, Yang M, Wang JH. Qi J, et al. Acta Pharmacol Sin. 2002 Jun;23(6):544-50. Acta Pharmacol Sin. 2002. PMID: 12060530 Free article.

7

[Preliminary studies on the mechanisms of a new anti-tumor agent PH II-7 with special preference to multidrug resistant tumor cells].

Tan YH, Qi J, Liu WJ, Yang CZ. Tan YH, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Apr;24(2):134-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002. PMID: 12905789 Chinese.

8

[Effects of 3-substituted aryl oxindole(PH II-7) on cell cycle of tumor cells].

Tan YH, Yang CZ, Qi J, Wang JH, Wang CY, Peng H. Tan YH, et al. Yao Xue Xue Bao. 2003 Nov;38(11):805-8. Yao Xue Xue Bao. 2003. PMID: 14991989 Chinese.

9

[Establishment of an imatinib resistant cell line K562/G01 and its characterization].

Qi J, Peng H, Gu ZL, Liang ZQ, Yang CZ. Qi J, et al. Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):337-41. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15308010 Chinese.

10

[An anti-P-gp/anti-CD3 bispecific antibody cytotoxic to human multidrug resistant KB cells].

Gao YD, Xiong DS, Yang M, Xu YF, Shao XF, Peng H, Fan DM, Yang CZ. Gao YD, et al. Zhonghua Zhong Liu Za Zhi. 2005 Nov;27(11):653-6. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438884 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,331 results

Search Page

Filters